Company Filing History:
Years Active: 2011
Title: Innovations of Fernando Pérez Cerdá in Demyelinating Diseases
Introduction
Fernando Pérez Cerdá is an accomplished inventor based in Leioa-Vizcaya, Spain. He has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of demyelinating diseases. His innovative approach utilizes specific biomarkers to enhance the understanding and management of these conditions.
Latest Patents
Fernando Pérez Cerdá holds a patent for a method aimed at the diagnosis and prognosis of demyelinating diseases. This invention focuses on the use of glutamate transporters, glutamate, and EGF to detect the presence of such diseases in individuals. It also helps determine the status or severity of the disease and monitor the effects of therapies administered to patients. The patent emphasizes the potential for developing new drugs by utilizing compounds that promote the expression of EAAT1 and EAAT2 transporters, as well as EGF, specifically for the treatment of multiple sclerosis (MS).
Career Highlights
Fernando is affiliated with the Universidad del País Vasco, where he continues to advance research in his field. His work has garnered attention for its innovative approach to addressing complex medical challenges. With a focus on improving patient outcomes, he has dedicated his career to exploring new therapeutic avenues.
Collaborations
Fernando has collaborated with notable colleagues, including Carlos Matute Almau and María Domercq García. These partnerships have enriched his research and contributed to the development of effective solutions for demyelinating diseases.
Conclusion
Fernando Pérez Cerdá's contributions to the field of medical science, particularly through his patent on diagnosing and treating demyelinating diseases, highlight his innovative spirit and commitment to improving healthcare. His work continues to pave the way for advancements in the treatment of these challenging conditions.